Rubius Therapeutics
+$2.00 (+8.49%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell RUBY and other stocks, options, and ETFs commission-free!
About RUBY
Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines for cancer, autoimmune diseases, hemophilia, and infectious and metabolic diseases. The company was founded by Avak Kahvejian, Jordi Mata-Fink, and Noubar Afeyan on April 26, 2013 and is headquartered in Cambridge, MA.
CEO
Pablo J. Cagnoni
Employees
204
Headquarters
Cambridge, Massachusetts
Founded
2013
RUBY Key Statistics
Market Cap
2.41B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
508.70K
High Today
$25.71
Low Today
$23.54
Open Price
$23.54
Volume
459.70K
52 Week High
$38.71
52 Week Low
$4.20
RUBY Earnings
-$0.60
-$0.56
-$0.51
-$0.47
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.52 per share
Actual
-$0.51 per share